XEOS MEDICAL
0738.435.957 · rovalta.com · 26/09/2026
ACTIVE
XEOS MEDICAL
Financial year 2025 · Closed on 31/12/2025
Net result-4,3 M €-17,6 %over 1 year
Gross margin-1,5 M €-24,4 %over 1 year
Equity4 M €+547,5 %over 1 year
Workforce23,9 ETP+4,8 %over 1 year
Overview
Identity
Source · BCE/KBOXEOS MEDICAL is a Public limited company incorporated in 2019. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 23,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0738.435.957
- Incorporation
- 26/11/2019
- Legal form
- Public limited company
- Registered office
- Kortrijksesteenweg 1084 box 301
9051 Gent · FlandreSee on map - Contributed capital
- 7 057 267,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 23,9 ETP
Activities (NACE)
Joint committees (2)
- 200
- 20000
Signals
Solid equityGood liquidityHealthy social debts
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,5 M € | -24.4% | -1,2 M € | +12.4% | -1,4 M € | -15.4% | -1,2 M € | -4.1% | -1,2 M € |
| EBITDA | -3,9 M € | -11.0% | -3,5 M € | -5.2% | -3,3 M € | -26.0% | -2,6 M € | -31.1% | -2 M € |
| Operating result | -4 M € | -9.8% | -3,6 M € | -7.9% | -3,4 M € | -26.7% | -2,7 M € | -32.1% | -2 M € |
| Net result | -4,3 M € | -17.6% | -3,7 M € | -8.5% | -3,4 M € | -26.4% | -2,7 M € | -32.8% | -2 M € |
| Balance sheet | |||||||||
| Equity | 4 M € | +548% | 620,9 k € | -71.4% | 2,2 M € | -27.3% | 3 M € | +77.6% | 1,7 M € |
| Total assets | 5,5 M € | +97.9% | 2,8 M € | +4.2% | 2,7 M € | -21.3% | 3,4 M € | +74.1% | 1,9 M € |
| Cash | 3,3 M € | +702% | 412 k € | -52.9% | 874,1 k € | -61.2% | 2,3 M € | +46.5% | 1,5 M € |
| Debts | 1,5 M € | -31.8% | 2,1 M € | +369% | 454,6 k € | +40.2% | 324,2 k € | +29.9% | 249,6 k € |
| Other | |||||||||
| Workforce | 23,9 ETP | +4.8% | 22,8 ETP | +30.3% | 17,5 ETP | +32.6% | 13,2 ETP | +41.9% | 9,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20256 active · 24 ended
Active mandates
Active
Lloyd Diamond
ActiveGuido Van der Schueren
ActivePatrick Keereman
ActiveWalter Mastelinck
ActiveEnded mandates
Lloyd Diamond
EndedLloyd Diamond
EndedOther companies at this address
Kortrijksesteenweg 1084 9051 Gent| Company | CBE no. |
|---|---|
CANTILLANA● Active | 0429.272.114 |
Cantillana Group● Active | 0735.402.926 |
Erudite Corporate● Active | 1010.598.854 |
Erudite.Health● Active | 0794.732.777 |
ERUDITE.HEALTH GLOBAL● Active | 1031.996.658 |
ERUDITE.HEALTH SPECTRUM● Active | 1031.996.559 |
Fire Engineered Solutions● Active | 0820.804.991 |
HARMONIZE IT● Active | 0899.434.379 |
NUTRIPHYT● Active | 0478.698.859 |
Trenker HoldCo● Active | 1010.598.656 |
Zentrick● Active | 0827.909.747 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 26/11/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 14 months |
| Filing date | 27/05/2026 | 11/06/2025 | 10/06/2024 | 17/05/2023 | 28/06/2022 | 10/06/2021 |
| General meeting | 12/05/2026 | 13/05/2025 | 14/05/2024 | 03/05/2023 | 18/05/2022 | 10/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 12/05/2026 | 27/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 13/05/2025 | 11/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 14/05/2024 | 10/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 03/05/2023 | 17/05/2023 | Dutch | |
| Abridged model | 31/12/2021 | 18/05/2022 | 28/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 10/05/2021 | 10/06/2021 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20256 active · 24 ended
Active mandates
Active
Lloyd Diamond
ActiveGuido Van der Schueren
ActivePatrick Keereman
ActiveWalter Mastelinck
ActiveEnded mandates
Lloyd Diamond
EndedLloyd Diamond
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates30/01/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates07/07/2025ONTSLAGEN - BENOEMINGEN
- Capital / shares30/08/2024KAPITAAL - AANDELEN
- Mandates01/07/2024ONTSLAGEN - BENOEMINGEN
- Registered office15/02/2024MAATSCHAPPELIJKE ZETEL
- Capital / shares02/10/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Capital / shares16/01/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates21/01/2022KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-4,3 M €↓
- 2024Annual accounts 2024-3,7 M €↓
- 2023Annual accounts 2023-3,4 M €↓
- 2022Annual accounts 2022-2,7 M €↓
- 2021Annual accounts 2021-2 M €↓
- 2020Annual accounts 2020-669,8 k €
- 26/11/2019IncorporationPublic limited company